New Approach could Starve Tumour Cells to Death
Posted by SR in News, tags: metabolism, oncology, transporterTumours are heterogeneous and contain both oxygenated and hypoxic regions. Cells in regions with low oxygen levels mainly use glucose for glycolytic energy production and release lactic acid in the process. It had been thought that tumour cells with an ample oxygen supply primarily used glucose for oxidative energy production, but a new study published in the Journal of Clinical Investigation shows that lactate plays a major role in fuelling the oxidative metabolism of these cells. Cells in different regions of a tumour are thus able to mutually regulate their access to energy metabolites, reserving glucose for use by cells in hypoxic regions and recycling their waste product. The study also identified the monocarboxylate transporter 1 (MCT1) as the main route of lactate uptake and, using three different tumour models, showed that blocking MCT1 with α-cyano-4-hydroxycinnamate or siRNA caused a switch from lactate-fuelled respiration to glycolysis. This switch in metabolism of oxygenated cells induces necrosis of distant hypoxic cells by effectively starving them of glucose. These hypoxic cells are known to be very aggressive and difficult to kill with conventional treatments. The reduced oxygen consumption by surviving tumour cells after MCT1 inhibition also rendered the tumours more sensitive to the effects of radiotherapy.
Since MCT1 is expressed in a variety of primary human tumours, the study demonstrates the therapeutic potential of MCT1 inhibitors, as well as the likely benefit of combining these with radiotherapy.
Related posts:
- New Drugs Could Make Tumour Cells More Sensitive to Radiotherapy In the rare inherited human disease, ataxia-telangiectasia (A-T), a mutation is present in a gene encoding a protein that normally...
- CD95: A Question of Life or Death Programmed cell death (apoptosis) is essential to maintain homeostasis within living organisms and is controlled by a variety of intra-...
- Targeting ‘Normal’ Cells to Treat Cancer Most cancer treatments directly target the cancerous cells but tumours are a heterogeneous mix of transformed cells and ‘normal’ cells....
- Strange Landscape of Cancer Cells Compared with the genome of a normal cell, that of a cancer cell has sections that are missing, repeated or...
- Role for PEAK1 Kinase in Tumour Metastasis The cytoskeleton plays a key role in regulating many cellular functions; it maintains cell shape, protects the cell, enables cellular...
Related posts brought to you by Yet Another Related Posts Plugin.
This entry was posted on Monday, December 8th, 2008 at 9:54 am and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
















Entries (RSS)